Edwards Lifesciences Completes Acquisitions of JenaValve Technology and Endotronix

Jul 25, 2024•about 1 year ago

Acquiring Company

Edwards Lifesciences

Acquired Company

JenaValve

Irvine

NapervilleMedical DeviceArtificial IntelligenceBiotechnologyHealth CareMedical DeviceBiotechnologyHealth CareManufacturingHealthcare

Description

Edwards Lifesciences today announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation. The company has entered into an agreement to acquire JenaValve Technology, a pioneer in the transcatheter treatment of aortic regurgitation and has exercised its option to acquire Endotronix, a leader in heart failure management solutions.

Company Information

Company

Edwards Lifesciences

Location

Irvine, California, United States

About

Edwards Lifesciences is the global leader of patient-focused innovations for structural heart disease and critical care monitoring. The company is dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape.

Related People

M&A Insights

Based on deal data

Integration timeline

70% of M&A integrations take 12-24 months to complete

Tech stack consolidation

83% of merged companies consolidate technology vendors within first year

Post-acquisition investment

Companies increase IT spending by 23% on average after acquisitions

Success factor

M&A deals with strong technology integration plans are 2.5x more likely to succeed